If you have results that were not fully available by the regular abstract submission deadline and are of critical importance, late-breaking may be a suitable venue for your work. This category is intended to recognize large clinical studies and high-impact translational research that would not have been completed in time for the regular abstract deadline.
You must submit an original work with results that were not fully available by the regular deadline. All submissions are reviewed and assessed based on quality, impact, and novelty. The abstract title and text must be clear and concise, and should clearly define the study/work presented. The submission should not include information already published in other scientific venues (either online or print).
Abstracts must be submitted by the presenting author, who is expected to attend the congress and present their work. During the Late Breaking session, the most outstanding abstracts will be selected for oral presentations and the rest will be presented as ePosters or paper posters.
You cannot submit a Late-Breaking submission from the same registration that you used to submit a research or education abstract to the main call for abstracts. Each registrant can only submit one Late-Breaking abstract and must choose between the clinical or laboratory-based categories. If you are submitting a clinical late-breaking abstract, the study must be prospective in design and authors must justify late consideration by documenting that closure of the trial was not possible prior to the deadline. Similarly, for laboratory-based late-breaking submissions, authors must justify why they could not complete the experiment by the regular abstract deadline.